pentobarbital will minimize the level or result of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Use of different therapies is strongly proposed when linagliptin is to be administered with a CYP3A4 inducerpentobarbital will lower the extent or effect of buprenorphine by influencing hepatic/intestinal enzym